Research location
Genova
GE, Italy
Advertisement
Research activity in Genova
GE, ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 93 trials and 97 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Genova
92 linked trials · page 1 of 2ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerNCT07007559 · 2025-12-10 · 1 site observation
RECRUITING
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLCNCT07356544 · 2025-08-12 · 1 site observation
RECRUITING
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate CancerNCT07093801 · 2025-07-30 · 2 site observations
RECRUITING
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.NCT06846281 · 2025-06-23 · 1 site observation
RECRUITING
Integrated Approach in Frail Older People with Atrial FibrillationNCT06775028 · 2024-04-11 · 1 site observation
RECRUITING
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.NCT05939414 · 2024-03-12 · 1 site observation
RECRUITING
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsNCT06008197 · 2024-01-17 · 1 site observation
RECRUITING
STep-up and Step-down Therapeutic Strategies in Childhood ARthritiSNCT03728478 · 2019-05-29 · 1 site observation
RECRUITING
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive VariablesNCT07533084 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)NCT07047118 · 2025-07-03 · 1 site observation
ACTIVE_NOT_RECRUITING
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"NCT06871501 · 2025-03-01 · 1 site observation
NOT_YET_RECRUITING
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple SclerosisNCT06617793 · 2025-02-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)NCT06675864 · 2024-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisNCT06655896 · 2024-10-29 · 1 site observation
ACTIVE_NOT_RECRUITING
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS PatientsNCT06345157 · 2024-07-30 · 1 site observation
ACTIVE_NOT_RECRUITING
ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer PatientsNCT06606535 · 2024-06-13 · 1 site observation
UNKNOWN
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPCNCT05849298 · 2024-01-03 · 1 site observation
ACTIVE_NOT_RECRUITING
BRING-UP 3 Heart FailureNCT06279988 · 2023-09-15 · 2 site observations
UNKNOWN
Impact of Mayzent on aSPMS Patients in a Long-term NIS in ItalyNCT05376579 · 2022-06-17 · 1 site observation
COMPLETED
Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical PracticeNCT05250011 · 2022-04-19 · 1 site observation
COMPLETED
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.NCT05038735 · 2021-12-17 · 1 site observation
ACTIVE_NOT_RECRUITING
GLUcose Transport and REnalPROtection in Chronic Kidney DiseaseNCT05998837 · 2021-04-13 · 1 site observation
COMPLETED
Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot UlcersNCT06680856 · 2021-02-23 · 1 site observation
COMPLETED
INTERFACE: hIv patieNts TracER For clinicAl assistanCe and rEsearch During COVID 19NCT05711680 · 2021-01-18 · 1 site observation
UNKNOWN
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"NCT04312503 · 2020-07-13 · 1 site observation
COMPLETED
Best EGFR-TKI Sequence in NSCLC Harboring EGFR MutationsNCT04811001 · 2020-06-12 · 1 site observation
UNKNOWN
Home-based EXergames To impRove cognitivE Function in MUltiple SclerosisNCT04169750 · 2020-03-01 · 1 site observation
UNKNOWN
Pediatric Long-Term Follow-up and Rollover StudyNCT03975829 · 2019-11-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Dose-range Finding Efficacy and Safety Study for QBW251 in COPD PatientsNCT04072887 · 2019-09-12 · 1 site observation
COMPLETED
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC SubjectsNCT03631199 · 2018-12-21 · 1 site observation
TERMINATED
Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus FulvestrantNCT03439046 · 2018-02-02 · 1 site observation
TERMINATED
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior TreatmentsNCT03056755 · 2017-08-29 · 1 site observation
COMPLETED
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinNCT02709512 · 2017-08-01 · 1 site observation
COMPLETED
BLITZ Heart FailureNCT03661060 · 2017-03-08 · 3 site observations
COMPLETED
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 1 site observation
COMPLETED
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody AvelumabNCT02926196 · 2016-06-17 · 1 site observation
COMPLETED
Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular GeometryNCT02851745 · 2015-07-01 · 1 site observation
COMPLETED
"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "NCT02530424 · 2015-05-01 · 1 site observation
COMPLETED
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.NCT03381326 · 2014-12-15 · 1 site observation
UNKNOWN
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast CancerNCT02278120 · 2014-11-20 · 1 site observation
COMPLETED
ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of CanakinumabNCT02296424 · 2014-11-17 · 1 site observation
COMPLETED
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation
COMPLETED
DRV/r + RPV QD: Efficacy and Toxicity ReductionNCT01792570 · 2014-09-30 · 1 site observation
COMPLETED
Long-term Follow-up of Fingolimod Phase II Study PatientsNCT02307838 · 2014-06-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenNCT01985334 · 2014-02-14 · 1 site observation
COMPLETED
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)NCT01824290 · 2014-02-05 · 1 site observation
COMPLETED
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast CancerNCT01958021 · 2013-12-17 · 1 site observation
COMPLETED
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.NCT01844765 · 2013-08-20 · 1 site observation
COMPLETED
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung CancerNCT01828099 · 2013-07-09 · 1 site observation
COMPLETED
QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)NCT01782326 · 2013-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.